BCAR1 and colorectal carcinoma: Experiments investigating the impact of BCAR1 and EREG on chemotherapy showed that reduction of BCAR1/p130Cas sensitizes CRC cells to FOLFIRI, whereas EREG had no effect itself and on p130Cas-mediated effects.